Pfizer faces losses seeing that Lipitor patent congealed to expire
CBS News LONDON – Pfizer faces substantial revenue loss this November as the deep pharma giants patent on the hugely widely held cholesterol drug Lipitor expires. This is panic generation, this is actually panic generation instead of the industry, Kenneth I. Kaitin, of the Centre designed for the Study of Drug Development next to Tufts University told The latest York epoch earlier this week. Pfizer at this time earns in the region of $10 billion a time on Lipitor sales deserted, according to The era. But Pfizer isnt and no-one else. selected of the companys main competitors additionally rise to lose billions to generic replications of their big-name drugs for instance a amount of patents are due to expire this time.